Global /United States /Healthcare /Drug Manufacturers - General /MGRX
chevron_leftBack
Mangoceuticals, Inc. logo

Mangoceuticals, Inc.

MGRX
NASDAQ: MGRX Delayed
0.3315USD -7.9%
As of 16 June 2026, Mangoceuticals, Inc. has a market cap of $5.62M USD, ranking #44048 globally and #5608 in the United States. It ranks #3906 in the Healthcare sector, and #1254 in the Drug Manufacturers - General industry.
Global Rank
44048
Country Rank
5608
Sector Rank
3906
Industry Rank
1254
Key Stats
Market Cap
$5.62MUSD
Enterprise Value
$4.59MUSD
Revenue (TTM)
$456.02KUSD
EBITDA (TTM)
-$15.87MUSD
Net Income (TTM)
-$21.82MUSD
PS Ratio
12.7
PB Ratio
0.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jacob Cohen open_in_new
Employees
3
Founded
2021
IPO
21 Mar 2023
Website
mangoceuticals.com open_in_new
1d 1w 1m 3m 6m 1y
-7.9% -26% -32% -23% -84% -81%

News

Loading...

MGRX Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
MGRX
Mangoceuticals Inc
ISIN: US56270V2051
Shares Out.:
17.167M1 Shares Float: 14.594M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
0.3315 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Mangoceuticals, Inc.

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Similar Companies

Industry: Drug Manufacturers - General (United States)
Name
Market Cap diff.
PE
LLY
$761.68B
14M%
38.1
JNJ
$547.28B
10M%
26.4
ABBV
$360.63B
6M%
97.4
MRK
$274.03B
5M%
15.1
PFE
$149.38B
3M%
19.5
$117.58B
2M%
16.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
$322.73B
256.25B CHF
6M%
19.9
AZN
$289.3B
215.59B GBP
5M%
27.6
NOVN
$275.68B
218.9B CHF
5M%
20.5
NOVO-B
$182.39B
1.18T DKK
3M%
11.5
SAN
$110.46B
95.26B EUR
2M%
19.9
GSK
$108.64B
80.96B GBP
2M%
14.6
chevron_leftBack